Asklepios BioPharmaceutical gets clearance for brain disease clinical trial

Asklepios BioPharmaceutical has received the go ahead for a clinical trial to look at gene therapy, BV-01, for Huntington’s Disease.

Related Keywords

Paris ,France General ,France ,Sheila Mikhail ,Nathalie Cartier Lacave ,Bayer Ag ,National Agency For Safety Of Medicines ,Health Products ,Committee For Orphan Medicinal Products ,European Union ,Ethics Committee ,European Medicines Agency ,Asklepios Biopharmaceutical Inc ,National Agency ,Asklepios Biopharmaceutical ,European Medicines ,Orphan Medicinal Products ,